BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37516949)

  • 1. 2B4 inhibits the apoptosis of natural killer cells through phosphorylated extracellular signal-related kinase/B-cell lymphoma 2 signal pathway.
    Mou J; Xie L; Xu Y; Zhou T; Liu Y; Huang Q; Tang K; Tian Z; Xing H; Qiu S; Rao Q; Wang M; Wang J
    Cytotherapy; 2023 Oct; 25(10):1080-1090. PubMed ID: 37516949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unidirectional signaling triggered through 2B4 (CD244), not CD48, in murine NK cells.
    Kim EO; Kim N; Kim TJ; Kim K; Kim TW; Kumar V; Lee KM
    J Leukoc Biol; 2010 Oct; 88(4):707-14. PubMed ID: 20647560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients.
    Meazza R; Falco M; Marcenaro S; Loiacono F; Canevali P; Bellora F; Tuberosa C; Locatelli F; Micalizzi C; Moretta A; Mingari MC; Moretta L; Aricò M; Bottino C; Pende D
    Eur J Immunol; 2017 Jun; 47(6):1051-1061. PubMed ID: 28386908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homotypic cell to cell cross-talk among human natural killer cells reveals differential and overlapping roles of 2B4 and CD2.
    Kim EO; Kim TJ; Kim N; Kim ST; Kumar V; Lee KM
    J Biol Chem; 2010 Dec; 285(53):41755-64. PubMed ID: 20813844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The murine NK receptor 2B4 (CD244) exhibits inhibitory function independent of signaling lymphocytic activation molecule-associated protein expression.
    Mooney JM; Klem J; Wülfing C; Mijares LA; Schwartzberg PL; Bennett M; Schatzle JD
    J Immunol; 2004 Sep; 173(6):3953-61. PubMed ID: 15356144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells.
    Messmer B; Eissmann P; Stark S; Watzl C
    J Immunol; 2006 Apr; 176(8):4646-50. PubMed ID: 16585556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of induction of NK activation by 2B4 (CD244) via its cognate ligand.
    Sinha SK; Gao N; Guo Y; Yuan D
    J Immunol; 2010 Nov; 185(9):5205-10. PubMed ID: 20881194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions.
    Lee KM; Forman JP; McNerney ME; Stepp S; Kuppireddi S; Guzior D; Latchman YE; Sayegh MH; Yagita H; Park CK; Oh SB; Wülfing C; Schatzle J; Mathew PA; Sharpe AH; Kumar V
    Blood; 2006 Apr; 107(8):3181-8. PubMed ID: 15905190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2B4 inhibits NK-cell fratricide.
    Taniguchi RT; Guzior D; Kumar V
    Blood; 2007 Sep; 110(6):2020-3. PubMed ID: 17537992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of the human 2B4 (CD244)/CD48 interaction: Lys68 and Glu70 in the V domain of 2B4 are critical for CD48 binding and functional activation of NK cells.
    Mathew SO; Kumaresan PR; Lee JK; Huynh VT; Mathew PA
    J Immunol; 2005 Jul; 175(2):1005-13. PubMed ID: 16002700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.
    Parolini S; Bottino C; Falco M; Augugliaro R; Giliani S; Franceschini R; Ochs HD; Wolf H; Bonnefoy JY; Biassoni R; Moretta L; Notarangelo LD; Moretta A
    J Exp Med; 2000 Aug; 192(3):337-46. PubMed ID: 10934222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subversion of natural killer cell responses by a cytomegalovirus-encoded soluble CD48 decoy receptor.
    Martínez-Vicente P; Farré D; Sánchez C; Alcamí A; Engel P; Angulo A
    PLoS Pathog; 2019 Apr; 15(4):e1007658. PubMed ID: 30947296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: the NK cell receptor 2B4 augments antigen-specific T cell cytotoxicity through CD48 ligation on neighboring T cells.
    Lee KM; Bhawan S; Majima T; Wei H; Nishimura MI; Yagita H; Kumar V
    J Immunol; 2003 May; 170(10):4881-5. PubMed ID: 12734329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylation affects ligand binding and function of the activating natural killer cell receptor 2B4 (CD244) protein.
    Margraf-Schönfeld S; Böhm C; Watzl C
    J Biol Chem; 2011 Jul; 286(27):24142-9. PubMed ID: 21606496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of natural killer receptor 2B4 bound to CD48 reveals basis for heterophilic recognition in signaling lymphocyte activation molecule family.
    Velikovsky CA; Deng L; Chlewicki LK; Fernández MM; Kumar V; Mariuzza RA
    Immunity; 2007 Oct; 27(4):572-84. PubMed ID: 17950006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2B4/CD48-mediated regulation of lymphocyte activation and function.
    Assarsson E; Kambayashi T; Persson CM; Chambers BJ; Ljunggren HG
    J Immunol; 2005 Aug; 175(4):2045-9. PubMed ID: 16081768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of adaptive NK cell expansion by macrophage-mediated phagocytosis inhibited by 2B4-CD48.
    Li R; Galindo CC; Davidson D; Guo H; Zhong MC; Qian J; Li B; Ruzsics Z; Lau CM; O'Sullivan TE; Vidal SM; Sun JC; Veillette A
    Cell Rep; 2024 Mar; 43(3):113800. PubMed ID: 38386559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of natural killer cell functions by interactions between 2B4 and CD48 in cis and in trans.
    Claus M; Wingert S; Watzl C
    Open Biol; 2016 May; 6(5):. PubMed ID: 27249817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of MHC class I proteins with the 2B4 receptor inhibits self-killing of human NK cells.
    Betser-Cohen G; Mizrahi S; Elboim M; Alsheich-Bartok O; Mandelboim O
    J Immunol; 2010 Mar; 184(6):2761-8. PubMed ID: 20164429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells.
    Vaidya SV; Stepp SE; McNerney ME; Lee JK; Bennett M; Lee KM; Stewart CL; Kumar V; Mathew PA
    J Immunol; 2005 Jan; 174(2):800-7. PubMed ID: 15634901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.